Skip to content
20-F

Annual Report (Foreign)

Taiwan Liposome Company, Ltd.

0001564590-21-016361

← back to feed
Filed
Mar 30, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2020 · Dec 31, 2020 79.01M sh
Shares Diluted FY 2020 · Dec 31, 2019 65.55M sh
Shares Diluted FY 2020 · Dec 31, 2018 62.72M sh
Shares Outstanding FY 2020 · Dec 31, 2020 84.15M sh
Operating Cash Flow FY 2020 · Dec 31, 2020 −$31.17M
Operating Cash Flow FY 2020 · Dec 31, 2020 −875.19M
Operating Cash Flow FY 2020 · Dec 31, 2019 −777.56M
Operating Cash Flow FY 2020 · Dec 31, 2018 −686.04M
Cash And Equivalents FY 2020 · Dec 31, 2020 $47.82M
Cash And Equivalents FY 2020 · Dec 31, 2020 1.34B
Cash And Equivalents restated FY 2020 · Dec 31, 2019 $36.46M
Cash And Equivalents FY 2020 · Dec 31, 2019 1.02B
Cash And Equivalents FY 2020 · Dec 31, 2018 807.48M
Cash And Equivalents FY 2020 · Dec 31, 2017 951.71M
Stockholders Equity FY 2020 · Dec 31, 2020 $30.75M
Stockholders Equity FY 2020 · Dec 31, 2020 863.33M
Stockholders Equity FY 2020 · Dec 31, 2019 721.91M
Stockholders Equity FY 2020 · Dec 31, 2018 669.2M
Stockholders Equity FY 2020 · Dec 31, 2017 987.28M
Current Liabilities FY 2020 · Dec 31, 2020 $12.4M
Current Liabilities FY 2020 · Dec 31, 2020 348.13M
Current Liabilities FY 2020 · Dec 31, 2019 556.7M
Total Liabilities FY 2020 · Dec 31, 2020 $31.56M
Total Liabilities FY 2020 · Dec 31, 2020 886.13M
Total Liabilities FY 2020 · Dec 31, 2019 664.07M
Current Assets FY 2020 · Dec 31, 2020 $51M
Current Assets FY 2020 · Dec 31, 2020 1.43B
Current Assets FY 2020 · Dec 31, 2019 1.1B
Total Assets FY 2020 · Dec 31, 2020 $62.3M
Total Assets FY 2020 · Dec 31, 2020 1.75B
Total Assets FY 2020 · Dec 31, 2019 1.39B
Eps Diluted FY 2020 · Dec 31, 2020 −$0.44
Eps Diluted FY 2020 · Dec 31, 2020 −12.42
Eps Diluted restated FY 2020 · Dec 31, 2019 −12.32
Eps Diluted FY 2020 · Dec 31, 2018 −14.37
Eps Basic FY 2020 · Dec 31, 2020 −$0.44
Eps Basic FY 2020 · Dec 31, 2020 −12.42
Eps Basic restated FY 2020 · Dec 31, 2019 −12.32
Eps Basic FY 2020 · Dec 31, 2018 −14.37
Rd Expense FY 2020 · Dec 31, 2020 $34.46M
Rd Expense FY 2020 · Dec 31, 2020 967.5M
Rd Expense FY 2020 · Dec 31, 2019 860.42M
Rd Expense FY 2020 · Dec 31, 2018 832.58M
Net Income FY 2020 · Dec 31, 2020 −$35.02M
Net Income FY 2020 · Dec 31, 2020 −983.31M
Net Income FY 2020 · Dec 31, 2019 −807.52M
Net Income FY 2020 · Dec 31, 2018 −901.57M
Operating Income FY 2020 · Dec 31, 2020 −$35.01M
Operating Income FY 2020 · Dec 31, 2020 −983.11M
Operating Income FY 2020 · Dec 31, 2019 −801.61M
Operating Income FY 2020 · Dec 31, 2018 −891.77M
Revenue FY 2020 · Dec 31, 2020 $3.63M
Revenue FY 2020 · Dec 31, 2020 101.93M
Revenue FY 2020 · Dec 31, 2019 209.14M
Revenue FY 2020 · Dec 31, 2018 62.32M